We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease (INTREPID)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01839396
Recruitment Status : Recruiting
First Posted : April 24, 2013
Last Update Posted : November 16, 2016
Information provided by (Responsible Party):
Boston Scientific Corporation

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2017
  Estimated Study Completion Date : July 2021

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 February 16, 2018 March 15, 2018